Showing results (31-40 of 566) with videos related to

Sort By:
Pageof 57
Annals of Hematology|January 25, 2002
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II studyM Uppenkamp, A Engert, V Diehl, et al.
European Journal of Cancer Care|September 14, 2006
Cost of illness of malignant lymphoma in GermanyA Reis, P Ihle, U Paulus, et al.
Studies in Health Technology and Informatics|February 24, 2001
Can factors influencing in-patient treatment in Hodgkin's disease be identified?--Retrospective analysis of HD6 patients of the GHSGB Pfistner, U Paulus, J P Glossmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 20, 2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesisM Scholz, A Engert, J Franklin, et al.
Leukemia & Lymphoma|August 3, 2002
T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factorsM Reiser, A Josting, M Soltani, et al.
Leukemia|January 22, 1998
A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myelomaK Hübel, H Tesch, B Kröger, et al.
Leukemia & Lymphoma|May 1, 1994
Experimental treatment of human Hodgkin's disease with ricin A-chain immunotoxinsA Engert, C Gottstein, U Winkler, et al.
Medizinische Klinik (Munich, Germany : 1983)|October 15, 1992
[New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?]A Engert, C Gottstein, U Winkler, et al.
Cancer Research|November 1, 1990
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibodyU Sahin, F Hartmann, P Senter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study GroupK Behringer, A Josting, P Schiller, et al.
Pageof 57